CA Patent

CA3097818A1 — 1-imidazothiadiazolo-2h-pyrrol-5-one derivatives

Assigned to UCB Biopharma SRL · Expires 2019-11-14 · 7y expired

What this patent protects

The present invention relates to 1-imidazothiadiazolo-2H-pyrrol-5-one derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals. (l)

USPTO Abstract

The present invention relates to 1-imidazothiadiazolo-2H-pyrrol-5-one derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals. (l)

Drugs covered by this patent

Patent Metadata

Patent number
CA3097818A1
Jurisdiction
CA
Classification
—
Expires
2019-11-14
Drug substance claim
No
Drug product claim
No
Assignee
UCB Biopharma SRL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.